The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation

Medical Science Monitor

Volumn 17, Issue 10, 2011, Pages

  Vokurka, Samuel ^a   Skardova, Jana ^a   Hruskova, Renata ^a   Kabatova Maxova, Klara ^a   Svoboda, Tomas ^a   Bystricka, Eva ^a   Steinerova, Katerina ^a   Koza, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Candida; Enterococcus; Gelclair; Microbiology; Nursing; Oral mucositis; Pain

Indexed keywords

ACICLOVIR; BENZYDAMINE; BUPRENORPHINE; BUSULFAN; CHLORHEXIDINE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; GELCLAIR; HYALURONIC ACID; MELPHALAN; MOUTHWASH; POLYVINYLPYRROLIDONE SODIUM HYALURONATE; POVIDONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIUM CULTURE; CANDIDA; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROCOCCUS FAECALIS; FEMALE; FUNGUS CULTURE; GARGLE; GEL; HUMAN; MALE; MICROBIAL COLONIZATION; MOUTH FLORA; ORAL MUCOSAL DISEASE; ORAL MUCOSITIS; PAIN; PAIN ASSESSMENT;

EID: 80054010801     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881983     Document Type: Article

References (17)

1. Barber C, Powell R, Ellis A et al: Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer, 2007; 15: 427-40
2. Bonassi L, Cotroneo G, Nastasi G et al: Treatment with Gelclair in patients suffering grade III-IV oral mucositis: effcacy and impact on quality of life (QOL). Anna Oncol, 2003; 14: 58
3. Flook C, Calman F, Mant M et al: Gelclair vs benzydamine in randomise controlled study in patients with oral mucositis due to radical radiotherapy. Support Care Cancer, 2005; 13: 443-444
4. Innocenti M, Moscatelli G, Lopez S: Effcacy of Gelclair in reducing pain in palliative care patients with oral lesions: preliminary fnding from an open pilot study. J Pain Symptom Manag, 2002; 24: 456-57
5. Buchsel PC" Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions. Expert Opin Drug Metab Toxicol, 2008; 4: 1449-54
6. Donnelly P, Bellm L, Epstein J et al: Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis, 2003; 7: 405-12
7. Karthaus M, Rosental C, Ganser A: Prophylaxis and treatment of che-mo- and radiotherapy-induced oral mucositis - are there new strategies? Bone Marrow Transplant, 1999; 24: 1095-108
8. Ferreti GA, Raybould TP, Brown AT et al: Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomised double-blind trial. Oral Surg Oral Med Oral Pathol, 1990; 69: 331-38
9. Weisdorf DJ, Bostrom B, Raether D et al: Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant, 1989; 4: 89-95
10. Aisa Y, Mori T, Kudo M et al: Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer, 2005; 13: 266-69
11. Svanberg A, Ohrn K, Birgegard G: Oral cryotherapy reduces mucosi-tis and improves nutrition - a randomised controlled trial. J Clin Nurs, 2010; 19: 2146-51
12. Rubenstein E, Peterson D, Schubert M et al: Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer, 2004; 100: 2026-46
13. Keefe D: Mucositis guidelines: what have they achieved, and where to from here. Support Care Cancer, 2006; 14: 489-91
14. Keefe DM, Schubert MM, Elting LS et al: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, 2007; 109(5): 820-31
15. Bensinger W, Schubert M, Ang KK et al: Task Force Report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw, 2008; 6: 1-21
16. Peterson D, Bensadoun RJ, Roila F: Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations. Ann Oncol, 2009; 20: 174-77
17. Misaki H, Iwasaki H, Ueda T: A comparison of the specifcity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases. Med Sci Monit, 2003; 9(2): MT1-7